🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very exciting approach! Finally the world of sHLA is opening up to us thanks to the IMBAS tech 🔥

I am honored to be joining the F.R.S.-FNRS as a tenured Research Associate. This position marks the culmination of my efforts in establishing my research group GIGA-ULiège 🥳🎉 Stay tuned for exciting explorations in #AML #immunogenomics #immunopeptidomics 🧬🔬

With autoimmune diseases, the body mistakenly attacks a person’s own cells – but a reverse vaccine could teach the immune system to forget how to target certain molecules. newscientist.com/article/239270…

Delighted to share that our latest article is now published in Leukemia Journal! Great work by the fantastic Nandita Noronha👍 We show that azacitidine should be combined with autophagy inhibitors to promote the immune recognition of leukemic cells in #AML🧐 go.nature.com/3UtWssx

❤️ 12.239.019,49€ au compteur du @televie 2024 ! Une générosité une fois encore exceptionnelle ! Grâce à vos dons, les chercheuses et chercheurs vont pouvoir continuer à améliorer la compréhension du cancer et ouvrir la voie à de nouvelles pistes thérapeutiques.

How do you define creativity? When asked, medicine laureate Susumu Tonegawa had an inspiring reply. Tonegawa was awarded the 1987 medicine prize "for his discovery of the genetic principle for generation of antibody diversity."

New #JITC article: ScRNA-seq reveals novel immune-suppressive T cells and investigates CMV-TCR-T cells cytotoxicity against GBM bit.ly/44mSSU6

Our latest preprint is out! We provide detailed protocols to study the #GVL effects against #AML in #NSG mice. This is the first first-author paper of my two brilliant PhD Students GIGA-ULiège, Charline & Bianca 🥳 biorxiv.org/content/10.110…

Online now! Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc dlvr.it/T6Njy2

The biggest myth about creativity is that it cannot be learned - either you have it or you don’t.. But psychologists have shown that creativity is linked with 'openness to experience' which increases with cultural activities, new hobbies, mental challenges and becoming awestruck.

Another example of how cryopreservation can bias our work... We need to find an affordable method to cryopreserve cells without altering their viability or phenotype 🤔

Curious to know what's cooking in our lab? Follow the guide with the very talented Bianca E Silva, as she unveils the exciting research happening behind the scenes! Thank you to the Fondation Léon Fredericq for the support and the highlight! youtube.com/watch?v=6CDp3v…

Excited to announce that our team has received a Welbio Starting Grant from the WEL Research Institute! This support will help us grow and develop novel #Immunotherapies against #Leukemia 💪🔬 Read more ➡️ bit.ly/4aFMY1X

Want to talk about immunopeptidomics pipelines at #ASMS2024? Come visit Jonas Scheid at poster 582!

Job alert! I am looking to hire a postdoc fellow to work on a Leukemia Immunology project funded by the WEL Research Institute at the GIGA-ULiège 👩‍🔬👨‍🔬 Apply here➡️bit.ly/3VtSFf5 EACR European Hematology Association EFIS #Postdoc #Academicjobs #researchJobs #AcademicTwitter

Interested to learn about #RNAVaccines for #cancer? Our thoughts now in Cancer Cell RNA Vaccines for cancer: Principles to Practice cell.com/cancer-cell/ab… Free pdf is here 👇🏽 authors.elsevier.com/a/1jDHe5TA51hO…

Maybe time to rethink the way we evaluate grant proposals?

😉😉😉

For our #CancerImmunology session, Gregory Ehx will talk about the "Identification of actionable targets for the development of immunotherapies against AML" #yBIS2024 Registrations: forms.gle/rbwB73YzGMxyiG… Abstracts: forms.gle/V2Lof7tMGevuDa…

Thank you very much to the yBIS for inviting me as a keynote speaker to their annual congress. It has been a true delight to present you our work and I look forward to attend next year's meeting!